ORCID identifier: 0000-0003-1622-5354
Selected Publications:
- Tianfang Ma, Lianjin Jin, Shanshan Bai, Zhan Liu, Shuo Wang, Beibei Shen, Yeyoung Cho, Subing Cao, Meijuan J. S. Sun, Ladan Fazli, David Zhang, Chiyaro Wedderburn, Derek Y. Zhang, Gavisha Mugon, Nathan Ungerleider, Melody Baddoo, Kun Zhang, Lovisa Holmberg Schiavone, Brant R. Burkhardt, Jia Fan, Zongbing You, Erik K. Flemington, Xuesen Dong, and Yan Dong. (2024) Loss of Feedback Regulation between FAM3B and Androgen Receptor Driving Prostate Cancer Progression, Journal of the National Cancer Institute (JNCI), 116, 421-433.
- Carlos M. Roggero, Lianjin Jin, Subing Cao, Rajni Sonavane, Noa G Kopplin, Hui Ta, Dede N Ekoue, Michael Witwer, Hong Liu, Tianfang Ma, Daniel Gioeli, Ganesh V. Raj, Yan Dong. (2021) A detailed characterization of stepwise activation of the androgen receptor variant 7 in prostate cancer cells. Oncogene, 40:1106–1117.
- Tianfang Ma, Shanshan Bai, Yanfeng Qi, Yang Zhan, Nathan Ungerleider, Derek Y. Zhang, Taavi Neklesa, Eva Corey, Scott M. Dehm, Kun Zhang, Erik K. Flemington, and Yan Dong. (2021) Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapy. Cancer Letters, 504:37-48.
- Subing Cao, Tianfang Ma, Nathan Ungerleider, Claire Roberts, Margaret Kobelski, Lianjin Jin, Monica Concha, Xia Wang, Melody Baddoo, Ladan Fazli, Holly M Nguyen, Eva Corey, Elisa Ledet, Rubin Zhang, Jonathan L. Silberstein, Wensheng Zhang, Kun Zhang, Oliver Sartor, Xuesen Dong, Erik K. Flemington, and Yan Dong. (2019) Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer. Oncogene, 38:7060-7072.
- Shanshan Bai, Subing Cao, Lianjin Jin, Margaret Kobelski, Blake Schouest, Xiaojie Wang, Nathan Ungerleider, Melody Baddoo, Wensheng Zhang, Eva Corey, Robert L. Vessella, Xuesen Dong, Kun Zhang, Xianghui Yu, Erik K. Flemington, and Yan Dong. (2019) A Positive Role of c-Myc in Regulating Androgen Receptor and its Splice Variants in Prostate Cancer. Oncogene, 38:4977–4989.
- Y Zhan, G Zhang, X Wang, Y Qi, S Bai, D Li, T Ma, O Sartor, EK Flemington, H Zhang, P Lee, and Y Dong. (2017) Interplay between cytoplasmic and nuclear androgen receptor splice variants mediate castration resistance. Molecular Cancer Research, 15, 59-68. Featured in the “Molecular Cancer Research Highlights: Selected Articles from This Issue” with a figure.
- D Xu, Y Zhan, Y Qi, B Cao, S Bai, W Xu, SS Gambhir, P Lee, O Sartor, EK Flemington, H Zhang, CD Hu, and Y Dong. (2015) Androgen receptor splice variants dimerize to transactivate target genes. Cancer Research, 75, 3663-3671. Editorial: Emmanuel S. Antonarakis and Jun Luo. (2015) AR splicevariant dimerization – clinical implications Nature Reviews Urology, 12,431-433.
Topics (Keywords/Tags): prostate cancer, androgen receptor, therapy resistance, TMPRSS2-ERG translocation